These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 32306353)
41. The serine 31 residue of the B subunit of Shiga toxin 2 is essential for secretion in enterohemorrhagic Escherichia coli. Shimizu T; Kawakami S; Sato T; Sasaki T; Higashide M; Hamabata T; Ohta T; Noda M Infect Immun; 2007 May; 75(5):2189-200. PubMed ID: 17325057 [TBL] [Abstract][Full Text] [Related]
42. Delivery of heterologous protein antigens via hemolysin or autotransporter systems by an attenuated ler mutant of rabbit enteropathogenic Escherichia coli. Zhu C; Ruiz-Perez F; Yang Z; Mao Y; Hackethal VL; Greco KM; Choy W; Davis K; Butterton JR; Boedeker EC Vaccine; 2006 May; 24(18):3821-31. PubMed ID: 16098637 [TBL] [Abstract][Full Text] [Related]
43. Bacteriophage cell lysis of Shiga toxin-producing Escherichia coli for top-down proteomic identification of Shiga toxins 1 & 2 using matrix-assisted laser desorption/ionization tandem time-of-flight mass spectrometry. Fagerquist CK; Zaragoza WJ Rapid Commun Mass Spectrom; 2016 Mar; 30(6):671-80. PubMed ID: 26864518 [TBL] [Abstract][Full Text] [Related]
44. Tumor delivery of ultrasound contrast agents using Shiga toxin B subunit. Couture O; Dransart E; Dehay S; Nemati F; Decaudin D; Johannes L; Tanter M Mol Imaging; 2011 Apr; 10(2):135-43. PubMed ID: 21439258 [TBL] [Abstract][Full Text] [Related]
45. Development and characterization of recombinant antibody fragments that recognize and neutralize in vitro Stx2 toxin from Shiga toxin-producing Escherichia coli. Luz D; Chen G; Maranhão AQ; Rocha LB; Sidhu S; Piazza RM PLoS One; 2015; 10(3):e0120481. PubMed ID: 25790467 [TBL] [Abstract][Full Text] [Related]
46. A real-time cell-binding assay reveals dynamic features of STxB-Gb3 cointernalization and STxB-mediated cargo delivery into cancer cells. Encarnação JC; Napolitano V; Opassi G; Danielson UH; Dubin G; Popowicz GM; Munier-Lehmann H; Buijs J; Andersson K; Björkelund H FEBS Lett; 2020 Aug; 594(15):2406-2420. PubMed ID: 32473599 [TBL] [Abstract][Full Text] [Related]
47. Analysis of Shiga toxin subunit association by using hybrid A polypeptides and site-specific mutagenesis. Jemal C; Haddad JE; Begum D; Jackson MP J Bacteriol; 1995 Jun; 177(11):3128-32. PubMed ID: 7768810 [TBL] [Abstract][Full Text] [Related]
48. Affinity-Based Screening of Tetravalent Peptides Identifies Subtype-Selective Neutralizers of Shiga Toxin 2d, a Highly Virulent Subtype, by Targeting a Unique Amino Acid Involved in Its Receptor Recognition. Mitsui T; Watanabe-Takahashi M; Shimizu E; Zhang B; Funamoto S; Yamasaki S; Nishikawa K Infect Immun; 2016 Sep; 84(9):2653-61. PubMed ID: 27382021 [TBL] [Abstract][Full Text] [Related]
49. Identification of a B subunit gene promoter in the Shiga toxin operon of Shigella dysenteriae 1. Habib NF; Jackson MP J Bacteriol; 1992 Oct; 174(20):6498-507. PubMed ID: 1400202 [TBL] [Abstract][Full Text] [Related]
50. Prevention and treatment of enterohemorrhagic Escherichia coli infections in humans. Orth D; Grif K; Zimmerhackl LB; Würzner R Expert Rev Anti Infect Ther; 2008 Feb; 6(1):101-8. PubMed ID: 18251667 [TBL] [Abstract][Full Text] [Related]
51. Pathogenesis of shigella diarrhea. XI. Isolation of a shigella toxin-binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide. Jacewicz M; Clausen H; Nudelman E; Donohue-Rolfe A; Keusch GT J Exp Med; 1986 Jun; 163(6):1391-404. PubMed ID: 3519828 [TBL] [Abstract][Full Text] [Related]
52. Activation of Src family kinase yes induced by Shiga toxin binding to globotriaosyl ceramide (Gb3/CD77) in low density, detergent-insoluble microdomains. Katagiri YU; Mori T; Nakajima H; Katagiri C; Taguchi T; Takeda T; Kiyokawa N; Fujimoto J J Biol Chem; 1999 Dec; 274(49):35278-82. PubMed ID: 10575015 [TBL] [Abstract][Full Text] [Related]
53. Globotriaosylceramide (Gb3) content in HeLa cells is correlated to Shiga toxin-induced cytotoxicity and Gb3 synthase expression. Shin IS; Ishii S; Shin JS; Sung KI; Park BS; Jang HY; Kim BW BMB Rep; 2009 May; 42(5):310-4. PubMed ID: 19470247 [TBL] [Abstract][Full Text] [Related]
54. Modification in media composition to obtain secretory production of STxB-based vaccines using Escherichia coli. Sadraeian M; Ghoshoon MB; Mohkam M; Karimi Z; Rasoul-Amini S; Ghasemi Y Virol Sin; 2013 Feb; 28(1):43-8. PubMed ID: 23329470 [TBL] [Abstract][Full Text] [Related]
55. Membrane invagination induced by Shiga toxin B-subunit: from molecular structure to tube formation. Pezeshkian W; Hansen AG; Johannes L; Khandelia H; Shillcock JC; Kumar PB; Ipsen JH Soft Matter; 2016 Jun; 12(23):5164-71. PubMed ID: 27070906 [TBL] [Abstract][Full Text] [Related]
56. Combining Mass Spectrometry, Surface Acoustic Wave Interaction Analysis, and Cell Viability Assays for Characterization of Shiga Toxin Subtypes of Pathogenic Escherichia coli Bacteria. Steil D; Pohlentz G; Legros N; Mormann M; Mellmann A; Karch H; Müthing J Anal Chem; 2018 Aug; 90(15):8989-8997. PubMed ID: 29939014 [TBL] [Abstract][Full Text] [Related]
57. Comparative Effect of Recombinant Shiga Toxin in Induction of Pro- and Anti-Apoptotic Markers and Inflammatory Cytokines in Epithelial and Monocytic Cells. Abedi Jafari F; Oloomi M; Bouzari S Jundishapur J Microbiol; 2016 Feb; 9(2):e24758. PubMed ID: 27127585 [TBL] [Abstract][Full Text] [Related]
58. Neutralizing activity of polyvalent Gb3, Gb2 and galacto-trehalose models against Shiga toxins. Neri P; Nagano SI; Yokoyama S; Dohi H; Kobayashi K; Miura T; Inazu T; Sugiyama T; Nishida Y; Mori H Microbiol Immunol; 2007; 51(6):581-92. PubMed ID: 17579269 [TBL] [Abstract][Full Text] [Related]
59. Shiga toxin signals via ATP and its effect is blocked by purinergic receptor antagonism. Johansson KE; Ståhl AL; Arvidsson I; Loos S; Tontanahal A; Rebetz J; Chromek M; Kristoffersson AC; Johannes L; Karpman D Sci Rep; 2019 Oct; 9(1):14362. PubMed ID: 31591425 [TBL] [Abstract][Full Text] [Related]